Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69


Loss of the 14-3-3σ tumor suppressor is a critical event in ErbB2-mediated tumor progression.

Ling C, Su VM, Zuo D, Muller WJ.

Cancer Discov. 2012 Jan;2(1):68-81. doi: 10.1158/2159-8290.CD-11-0189. Epub 2011 Nov 29.


The 14-3-3σ tumor suppressor has multiple functions in ErbB2-induced breast cancer.

Hynes NE, Smirnova T.

Cancer Discov. 2012 Jan;2(1):19-22. doi: 10.1158/2159-8290.CD-11-0317.


beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.

Huck L, Pontier SM, Zuo DM, Muller WJ.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15559-64. doi: 10.1073/pnas.1003034107. Epub 2010 Aug 16.


Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.

Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.

Exp Mol Pathol. 2001 Jun;70(3):183-93.


Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.

Andrechek ER, Muller WJ.

Cell Cycle. 2004 Sep;3(9):1111-3. Epub 2004 Sep 1. Review.


The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.


A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.

Dearth RK, Kuiatse I, Wang YF, Liao L, Hilsenbeck SG, Brown PH, Xu J, Lee AV.

BMC Cancer. 2011 Aug 25;11:377. doi: 10.1186/1471-2407-11-377.


Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.

Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG.

Cell. 2006 Aug 11;126(3):489-502.


β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.

Schade B, Lesurf R, Sanguin-Gendreau V, Bui T, Deblois G, O'Toole SA, Millar EK, Zardawi SJ, Lopez-Knowles E, Sutherland RL, Giguère V, Kahn M, Hallett M, Muller WJ.

Cancer Res. 2013 Jul 15;73(14):4474-87. doi: 10.1158/0008-5472.CAN-12-3925. Epub 2013 May 29.


The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.

Cancer Res. 2003 Jun 15;63(12):3395-402.


A novel role for 14-3-3sigma in regulating epithelial cell polarity.

Ling C, Zuo D, Xue B, Muthuswamy S, Muller WJ.

Genes Dev. 2010 May;24(9):947-56. doi: 10.1101/gad.1896810.


Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.

Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ.

Cancer Res. 2004 May 1;64(9):3171-8.


Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.

Andrechek ER, Hardy WR, Laing MA, Muller WJ.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4984-9. Epub 2004 Mar 29.


Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.

Cadieux C, Kedinger V, Yao L, Vadnais C, Drossos M, Paquet M, Nepveu A.

Cancer Res. 2009 Sep 15;69(18):7188-97. doi: 10.1158/0008-5472.CAN-08-4899. Epub 2009 Sep 8.


Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.

Ursini-Siegel J, Rajput AB, Lu H, Sanguin-Gendreau V, Zuo D, Papavasiliou V, Lavoie C, Turpin J, Cianflone K, Huntsman DG, Muller WJ.

Mol Cell Biol. 2007 Sep;27(18):6361-71. Epub 2007 Jul 16.


Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.

Peng M, Ball-Kell SM, Tyner AL.

Cell Death Dis. 2015 Aug 6;6:e1848. doi: 10.1038/cddis.2015.210.


p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.

Hulit J, Lee RJ, Li Z, Wang C, Katiyar S, Yang J, Quong AA, Wu K, Albanese C, Russell R, Di Vizio D, Koff A, Thummala S, Zhang H, Harrell J, Sun H, Muller WJ, Inghirami G, Lisanti MP, Pestell RG.

Cancer Res. 2006 Sep 1;66(17):8529-41.


ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.

Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR, Arteaga CL.

Mol Cell Biol. 2002 Apr;22(7):2204-19.


Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.

Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Zhou P, Stipp CS, Kaetzel DM, Hemler ME, Yang XH.

Neoplasia. 2012 Aug;14(8):678-89.

Supplemental Content

Support Center